Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novelion Therapeutics Inc (NASDAQ:NVLN)

During the Trading Day
9.69 -0.25 / -2.52%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
9.69 0.00 / 0.00%
 
Volume: 276.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.0013.6M
 
 
Cost of Goods Sold0.000.000.003.6M
 
 
Depreciation And Amortization964.0K891.0K576.0K2.4M
 
 
 
 
 
 
Operating ExpensesGross Income-964.0K-891.0K-576.0K7.6M
 
 
 
 
 
General Expenses25.5M20.4M16.0M44.3M
 
 
 
 
 
Research And Development18.5M13.8M9.8M14.8M
 
 
 
 
 
Total Operating Expenses26.5M21.3M16.6M50.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.5M-21.3M-16.6M-36.7M
 
 
 
 
 
Extraordinary Credit2.9M17.5M0.000.00
 
 
 
Extraordinary Charge-2.0M-534.0K-6.7M-10.7M
 
 
 
 
 
Interest Expense On Debt0.000.000.003.0M
 
 
Other Expenses175.0K53.0K81.0K-2.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.2M-4.2M-23.0M-52.4M
 
 
 
 
 
Income Taxes-599.0K-192.0K-22.0K-465.0K
 
 
 
 
 
Discontinued Operations967.0K-66.0K0.000.00
 
 
 
Net Income-24.9M-4.1M-23.0M-52.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.2M10.2M10.4M11.3M
 
 
 
 
 
Shares To Calculate EPS Diluted10.2M10.2M10.4M11.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.45-$0.40-$2.20-$4.69
 
 
 
 
 
EPS Diluted-$2.45-$0.40-$2.20-$4.69